Benjamin P. Davis

1.7k total citations
31 papers, 978 citations indexed

About

Benjamin P. Davis is a scholar working on Surgery, Rheumatology and Immunology. According to data from OpenAlex, Benjamin P. Davis has authored 31 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Rheumatology and 8 papers in Immunology. Recurrent topics in Benjamin P. Davis's work include Eosinophilic Esophagitis (12 papers), Eosinophilic Disorders and Syndromes (9 papers) and IL-33, ST2, and ILC Pathways (5 papers). Benjamin P. Davis is often cited by papers focused on Eosinophilic Esophagitis (12 papers), Eosinophilic Disorders and Syndromes (9 papers) and IL-33, ST2, and ILC Pathways (5 papers). Benjamin P. Davis collaborates with scholars based in United States, Spain and Canada. Benjamin P. Davis's co-authors include Marc E. Rothenberg, Jared Travers, Mark Rochman, Jeffrey K. Rymer, Leah C. Kottyan, Emily M. Stucke, Vladislav A. Litosh, Jonathan A. Bernstein, Zuhair K. Ballas and Linda Levin and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Benjamin P. Davis

30 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin P. Davis United States 12 404 306 301 219 166 31 978
Miho Okuda Japan 15 227 0.6× 97 0.3× 55 0.2× 100 0.5× 99 0.6× 40 885
Kazunori Yoneda Japan 22 157 0.4× 155 0.5× 72 0.2× 69 0.3× 119 0.7× 75 1.3k
Ilja Tchetverikov Netherlands 17 137 0.3× 410 1.3× 756 2.5× 56 0.3× 33 0.2× 54 1.2k
Sabine G. Plötz Germany 14 329 0.8× 348 1.1× 518 1.7× 382 1.7× 350 2.1× 22 1.1k
Mona Biermann Germany 17 51 0.1× 902 2.9× 201 0.7× 111 0.5× 126 0.8× 28 1.2k
Mariateresa Rossi Italy 18 75 0.2× 184 0.6× 104 0.3× 57 0.3× 49 0.3× 85 941
Scott D. Meredith United States 12 226 0.6× 74 0.2× 59 0.2× 167 0.8× 221 1.3× 15 768
Michaela Fux Switzerland 15 55 0.1× 260 0.8× 80 0.3× 112 0.5× 111 0.7× 30 575
Marlies de Graaf Netherlands 17 290 0.7× 77 0.3× 96 0.3× 252 1.2× 124 0.7× 63 867
Chih‐Hsun Yang Taiwan 18 198 0.5× 85 0.3× 162 0.5× 20 0.1× 87 0.5× 62 868

Countries citing papers authored by Benjamin P. Davis

Since Specialization
Citations

This map shows the geographic impact of Benjamin P. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin P. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin P. Davis more than expected).

Fields of papers citing papers by Benjamin P. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin P. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin P. Davis. The network helps show where Benjamin P. Davis may publish in the future.

Co-authorship network of co-authors of Benjamin P. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin P. Davis. A scholar is included among the top collaborators of Benjamin P. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin P. Davis. Benjamin P. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rachid, Rima, Brian P. Vickery, Andrew J. MacGinnitie, et al.. (2025). Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. UNC Libraries. 1 indexed citations
2.
Davis, Benjamin P., et al.. (2023). Toxic Epidermal Necrolysis after COVID-19 mRNA-1237 Vaccination. SHILAP Revista de lepidopterología. 2023. 1–2. 1 indexed citations
3.
5.
Rahhal, Riad, et al.. (2022). Refractory Pediatric Fibrostenotic Eosinophilic Esophagitis Treated With Dupilumab. ACG Case Reports Journal. 9(11). e00887–e00887. 9 indexed citations
7.
Jones, Stacie M., Brian P. Vickery, J. Andrew Bird, et al.. (2017). At-home Dosing Adherence During Characterized Oral Desensitization Immunotherapy (CODIT) for Peanut Allergy. Journal of Allergy and Clinical Immunology. 139(2). AB256–AB256. 1 indexed citations
8.
Hassan, Umer, Tanmay Ghonge, Bobby Reddy, et al.. (2017). A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification. Nature Communications. 8(1). 15949–15949. 113 indexed citations
9.
Bird, J. Andrew, Jonathan M. Spergel, Stacie M. Jones, et al.. (2017). Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. The Journal of Allergy and Clinical Immunology In Practice. 6(2). 476–485.e3. 142 indexed citations
10.
Rochman, Mark, Jared Travers, Ting Wen, et al.. (2017). Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 140(3). 738–749.e3. 64 indexed citations
11.
Davis, Benjamin P. & Zuhair K. Ballas. (2017). Biologic response modifiers: Indications, implications, and insights. Journal of Allergy and Clinical Immunology. 139(5). 1445–1456. 23 indexed citations
12.
Davis, Benjamin P., Emily M. Stucke, Vladislav A. Litosh, et al.. (2016). Eosinophilic esophagitis–linked calpain 14 is an IL-13–induced protease that mediates esophageal epithelial barrier impairment. JCI Insight. 1(4). e86355–e86355. 127 indexed citations
13.
Davis, Benjamin P., Leah C. Kottyan, Lisa J. Martin, et al.. (2015). Association of eosinophilic esophagitis and hypertrophic cardiomyopathy. Journal of Allergy and Clinical Immunology. 137(3). 934–936.e5. 11 indexed citations
14.
Levin, Linda, et al.. (2013). Asthma screening of inner city and urban elementary school-aged children. Journal of Asthma. 50(10). 1049–1055. 5 indexed citations
15.
Davis, Benjamin P. & Marc E. Rothenberg. (2013). Emerging concepts of dietary therapy for pediatric and adult eosinophilic esophagitis. Expert Review of Clinical Immunology. 9(4). 285–287. 9 indexed citations
16.
Bogoch, Isaac I., Rodrigo B. Cavalcanti, Arnold N. Weinberg, & Benjamin P. Davis. (2012). Web‐based blog supplement to evidence‐based physical examination teaching. Medical Education. 46(5). 508–508. 7 indexed citations
17.
Bernstein, Jonathan A., et al.. (2011). A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Annals of Allergy Asthma & Immunology. 107(2). 171–178. 47 indexed citations
18.
19.
Rooney, Cyril P., Gerene M. Denning, Benjamin P. Davis, et al.. (2002). Bronchoalveolar Fluid Is Not a Major Hindrance to Virus-Mediated Gene Therapy in Cystic Fibrosis. Journal of Virology. 76(20). 10437–10443. 8 indexed citations
20.
Noffsinger, Amy, et al.. (1997). Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Human Pathology. 28(3). 270–276. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026